Veracyte Inc

VCYT · NASDAQ · Healthcare / Diagnostics & Research

24.33USD-0.30 (-1.22%)

Price History

Full chart

Market Stats

Previous Close24.63

Open24.49

Day Range23.45 – 24.65

52-Week Range29.46 – 60.91

Volume2.03M

Market Cap3.64B

P/E (TTM)32.54

Forward P/E23.58

EPS1.39

Dividend Yield0.00%

Beta1.93

50-Day Avg45.96

200-Day Avg42.46

About

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEOMr. Marc A. Stapley
Employees755
Headquarters6000 Shoreline Court, South San Francisco, CA, United States, 94080, USA
Websitehttps://www.veracyte.com

Leadership

Mr. Marc A. StapleyCEO & Director · b. 1970
Ms. Rebecca ChambersExecutive VP & CFO · b. 1978
Dr. Phillip G. Febbo M.D.Chief Scientific & Medical Officer · b. 1966
Ms. Annie McGuireExecutive VP, General Counsel & Head of Market Access · b. 1980
Dr. John Leite Ph.D.Global Chief Commercial Officer · b. 1972
Dr. Keith Gligorich Ph.D.Senior Vice President of Global Operations
Mr. Jonathan WygantVP & Chief Accounting Officer · b. 1971
Dr. Kevin Richard Haas Ph.D.Chief Development & Technology Officer · b. 1985
Mr. Steven FrenchSenior VP & Chief Information Officer
Ms. Kelly GuraDirector of Investor Relations

Financials

Income Statement

Currency: USD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.65M	11.63M	21.88M	38.19M	49.50M	65.08M	71.95M	92.01M	120.37M	117.48M	219.51M	296.54M	361.05M	445.76M	517.14M
Growth (%)	-	+339.62%	+88.20%	+74.51%	+29.62%	+31.48%	+10.55%	+27.87%	+30.82%	-2.40%	+86.85%	+35.09%	+21.76%	+23.46%	+16.01%
Cost of Revenue	2.92M	7.58M	12.61M	16.61M	21.50M	25.46M	28.20M	33.08M	36.52M	41.45M	74.40M	101.58M	112.90M	147.62M	157.10M
Gross Profit	-280.00K	4.04M	9.28M	21.58M	28.01M	39.62M	43.76M	58.93M	83.84M	76.03M	145.11M	194.95M	248.15M	298.14M	360.05M
Gross Margin	-10.59%	34.78%	42.39%	56.52%	56.57%	60.88%	60.81%	64.05%	69.66%	64.71%	66.11%	65.74%	68.73%	66.88%	69.62%
Operating Expense	14.99M	22.97M	32.45M	50.59M	61.47M	68.43M	70.30M	81.16M	98.97M	111.42M	227.02M	236.03M	333.94M	282.00M	285.89M
Operating Income	-15.27M	-18.93M	-23.17M	-29.01M	-33.47M	-28.80M	-26.54M	-22.23M	-15.13M	-35.39M	-81.90M	-41.08M	-85.80M	16.14M	74.15M
Operating Margin	-577.16%	-162.79%	-105.89%	-75.95%	-67.60%	-44.25%	-36.88%	-24.16%	-12.57%	-30.12%	-37.31%	-13.85%	-23.76%	3.62%	14.34%
EBITDA	-13.83M	-17.94M	-24.35M	-28.93M	-32.53M	-25.09M	-23.76M	-17.12M	-7.80M	-26.74M	-60.18M	-6.98M	-49.41M	49.20M	89.62M
EBITDA Margin	-523.02%	-154.31%	-111.26%	-75.76%	-65.71%	-38.55%	-33.03%	-18.60%	-6.48%	-22.76%	-27.42%	-2.35%	-13.68%	11.04%	17.33%
Net Income	-14.45M	-18.65M	-25.58M	-29.37M	-33.70M	-31.36M	-31.00M	-23.00M	-12.60M	-34.91M	-75.56M	-36.56M	-74.40M	24.14M	66.35M
Net Income Margin	-546.12%	-160.38%	-116.89%	-76.91%	-68.08%	-48.18%	-43.09%	-25.00%	-10.47%	-29.71%	-34.42%	-12.33%	-20.61%	5.41%	12.83%
R&D	6.68M	6.61M	7.81M	9.80M	12.80M	15.32M	13.88M	14.82M	14.85M	17.20M	29.84M	40.60M	57.30M	69.29M	70.81M
R&D as % of Total Revenue	252.55%	56.83%	35.69%	25.67%	25.85%	23.54%	19.29%	16.11%	12.34%	14.64%	13.60%	13.69%	15.87%	15.54%	13.69%
Interest Expense	0	0	233.00K	439.00K	378.00K	2.76M	4.94M	1.96M	677.00K	229.00K	241.00K	198.00K	15.00K	2.00K	1.00K
Interest Expense % of Total Revenue	0.00%	0.00%	1.06%	1.15%	0.76%	4.24%	6.87%	2.13%	0.56%	0.19%	0.11%	0.07%	0.00%	0.00%	0.00%

Balance Sheet

Currency: USD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	10.45M	19.07M	79.63M	64.84M	75.28M	101.03M	78.67M	120.64M	275.21M	457.16M	1.19B	1.16B	1.11B	1.30B	1.41B
Total Liabilities	1.92M	14.17M	23.19M	23.46M	24.03M	41.45M	41.44M	40.88M	35.76M	35.93M	91.31M	81.22M	70.80M	124.07M	96.44M
Total Equity	8.53M	4.90M	56.44M	41.37M	51.25M	59.58M	37.23M	79.75M	239.46M	421.23M	1.10B	1.08B	1.04B	1.18B	1.31B
Cash	7.57M	14.00M	71.22M	35.01M	39.08M	59.22M	33.89M	78.00M	159.32M	349.36M	173.20M	154.25M	216.45M	239.09M	362.58M
Total Debt	-	-	4.90M	4.92M	10.02M	25.52M	25.25M	25.28M	13.61M	12.32M	18.85M	14.72M	12.63M	50.74M	39.65M
Net Debt	-7.57M	-14.00M	-66.32M	-30.09M	-34.06M	-33.70M	-8.64M	-52.71M	-145.71M	-337.05M	-154.34M	-139.53M	-203.82M	-188.35M	-322.92M

Cash Flow

Currency: USD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-13.52M	-7.17M	-19.16M	-27.63M	-26.96M	-27.98M	-23.91M	-13.52M	-3.23M	-9.71M	-31.62M	7.54M	44.22M	75.10M	136.31M
Investing Cash Flow	-331.00K	-1.46M	-1.28M	-9.01M	-6.70M	-4.21M	-1.20M	-1.87M	-42.73M	-3.84M	-739.21M	-29.39M	15.11M	-56.27M	-9.21M
Financing Cash Flow	18.65M	15.06M	77.66M	436.00K	37.73M	52.33M	-218.00K	59.50M	127.29M	203.59M	596.32M	3.49M	2.84M	4.90M	-4.22M
Capital Expenditure	276.00K	1.46M	1.33M	2.02M	6.17M	4.21M	1.75M	1.87M	2.76M	2.84M	5.38M	8.55M	9.96M	11.29M	9.68M
Free Cash Flow	-13.80M	-8.63M	-20.49M	-29.66M	-33.13M	-32.19M	-25.67M	-15.39M	-5.99M	-12.55M	-37.00M	-1.01M	34.26M	63.81M	126.63M
Dividends Paid	-	-	0	9.27M	0	0	0	-	977.00K	3.85M	-	3.17M	-	-	-
FCF to OCF	102.04%	120.40%	106.95%	107.32%	122.86%	115.05%	107.34%	113.86%	185.27%	129.21%	117.00%	-13.46%	77.48%	84.97%	92.90%
Dividend Paid to FCF	-	-	0.00%	-31.27%	0.00%	0.00%	0.00%	-	-16.32%	-30.64%	-	-312.33%	-	-	-

Earnings

Report Date	Nov 25, 2013	Mar 18, 2014	May 8, 2014	Aug 13, 2014	Nov 13, 2014	Mar 19, 2015	May 14, 2015	Aug 13, 2015	Nov 5, 2015	Mar 10, 2016	May 5, 2016	Aug 3, 2016	Nov 3, 2016	Mar 1, 2017	May 3, 2017	Jul 31, 2017	Nov 6, 2017	Feb 27, 2018	May 1, 2018	Jul 23, 2018	Oct 29, 2018	Feb 25, 2019	Apr 30, 2019	Jul 30, 2019	Oct 22, 2019	Feb 25, 2020	May 6, 2020	Jul 30, 2020	Nov 2, 2020	Feb 17, 2021	May 10, 2021	Jul 29, 2021	Nov 9, 2021	Feb 28, 2022	May 3, 2022	Aug 2, 2022	Nov 2, 2022	Feb 22, 2023	May 4, 2023	Aug 8, 2023	Nov 7, 2023	Feb 22, 2024	May 7, 2024	Aug 6, 2024	Nov 6, 2024	Feb 20, 2025	May 7, 2025	Aug 6, 2025	Nov 4, 2025	Feb 25, 2026	May 5, 2026	Jul 30, 2026	Nov 3, 2026
EPS Estimate	-	-0.38	-0.31	-0.33	-0.35	-0.33	-0.36	-0.31	-0.33	-0.30	-0.35	-0.33	-0.21	-0.26	-0.23	-0.25	-0.21	-0.20	-0.25	-0.26	-0.21	-0.15	-0.07	-0.09	-0.07	-0.07	-0.20	-0.27	-0.19	-0.10	-0.12	-0.25	-0.14	-0.16	-0.23	-0.22	-0.23	-0.15	-0.11	-0.14	-0.13	-0.09	-0.10	-0.01	0.17	0.26	0.20	0.30	0.32	0.39	0.33	0.29	0.28
EPS Actual	-0.30	-0.42	-0.32	-0.31	-0.37	-0.36	-0.34	-0.35	-0.32	-0.29	-0.36	-0.40	-0.20	-0.14	-0.24	-0.22	-0.21	-0.24	-0.27	-0.18	-0.12	-0.08	-0.05	-0.05	-0.02	-0.15	-0.24	-0.22	-0.08	-0.14	-0.66	-0.13	-0.20	-0.15	-0.20	-0.13	-0.12	-0.05	-0.11	-0.12	-0.41	-0.39	0.04	0.30	0.33	0.36	0.31	0.44	0.51	0.53	0.52	0.37	-
Surprise	-	-10.53%	-3.23%	6.06%	-5.71%	-9.09%	5.56%	-12.90%	3.03%	3.33%	-2.86%	-21.21%	4.76%	46.15%	-4.35%	12.00%	0.00%	-20.00%	-8.00%	30.77%	42.86%	46.67%	28.57%	44.44%	71.43%	-114.29%	-20.00%	18.52%	57.89%	-40.00%	-450.00%	48.00%	-42.86%	6.25%	13.04%	40.91%	47.83%	66.67%	0.00%	14.29%	-215.38%	-333.33%	140.00%	3100.00%	94.12%	40.02%	55.00%	46.67%	59.38%	35.90%	57.58%	27.59%	-
Timing	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap3.64B

Enterprise Value3.08B

Trailing P/E32.54

Forward P/E23.58

PEG Ratio0.00

Price / Sales6.47

Price / Book2.54

EPS1.39

Book Value17.28

Revenue (TTM)561.90M

Gross Profit (TTM)414.44M

EBITDA113.52M

Profit Margin20.37%

Operating Margin15.29%

Return on Equity8.77%

Return on Assets4.09%

Shares Outstanding80.39M

Shares Float79.88M

Beta1.93

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Buy

Based on 11 analystsTarget 58.42

Strong Buy
8
Buy
1
Hold
1
Strong Sell
1

Ownership Breakdown

Institutions: 113.40%
Insiders: 0.49%
Retail / Other: 0.00%

Top Institutional Holders

BlackRock Inc
13.17M16.39%
FMR Inc
7.76M9.66%
Artisan Partners Limited Partnership
5.54M6.89%
State Street Corp
5.04M6.27%
Vanguard Portfolio Management, LLC
4.44M5.53%
Vanguard Capital Management, LLC
3.53M4.39%
ARK Investment Management LLC
3.05M3.80%
Dimensional Fund Advisors, Inc.
2.83M3.52%
First Trust Advisors L.P.
2.51M3.12%
Wellington Management Company LLP
2.27M2.83%
Geode Capital Management, LLC
1.96M2.43%
Bank of America Corp
1.45M1.80%
GW&K Investment Management, LLC
1.44M1.79%
William Blair Investment Management, LLC
1.43M1.78%

Top Fund Holders

iShares Core S&P Small-Cap ETF
4.87M6.05%
Vanguard MStar Total Stk Mkt Idx Invest
2.54M3.16%
iShares Russell 2000 ETF
2.06M2.56%
Vanguard Small Cap Index
1.83M2.28%
First Trust NYSE Arca Biotech ETF
1.59M1.98%
State Street® SPDR® S&P® Biotech ETF
1.57M1.96%